183 related articles for article (PubMed ID: 33404124)
1. ANO9 regulates PD-L2 expression and binding ability to PD-1 in gastric cancer.
Katsurahara K; Shiozaki A; Kosuga T; Shimizu H; Kudou M; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Otsuji E
Cancer Sci; 2021 Mar; 112(3):1026-1037. PubMed ID: 33404124
[TBL] [Abstract][Full Text] [Related]
2. ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer.
Jun I; Park HS; Piao H; Han JW; An MJ; Yun BG; Zhang X; Cha YH; Shin YK; Yook JI; Jung J; Gee HY; Park JS; Yoon DS; Jeung HC; Lee MG
Br J Cancer; 2017 Dec; 117(12):1798-1809. PubMed ID: 29024940
[TBL] [Abstract][Full Text] [Related]
3. ANO9 Regulated Cell Cycle in Human Esophageal Squamous Cell Carcinoma.
Katsurahara K; Shiozaki A; Kosuga T; Kudou M; Shoda K; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Marunaka Y; Otsuji E
Ann Surg Oncol; 2020 Sep; 27(9):3218-3230. PubMed ID: 32227267
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism of the programmed death-ligand 1 gene is associated with its protein expression and prognosis in gastric cancer.
Wu Y; Zhao T; Jia Z; Cao D; Cao X; Pan Y; Zhao D; Zhang B; Jiang J
J Gastroenterol Hepatol; 2019 Jul; 34(7):1201-1207. PubMed ID: 30353572
[TBL] [Abstract][Full Text] [Related]
5. Profiles of PD-1, PD-L1, PD-L2 in Gastric Cancer and Their Relation with Mutation, Immune Infiltration, and Survival.
Liu J; Li H; Sun L; Yuan Y; Xing C
Biomed Res Int; 2020; 2020():2496582. PubMed ID: 32596285
[TBL] [Abstract][Full Text] [Related]
6. Immune suppression caused by PD-L2 expression on tumor cells in gastric cancer.
Nakayama Y; Mimura K; Kua LF; Okayama H; Min AKT; Saito K; Hanayama H; Watanabe Y; Saito M; Momma T; Saze Z; Ohki S; Suzuki Y; Ichikawa D; Yong WP; Kono K
Gastric Cancer; 2020 Nov; 23(6):961-973. PubMed ID: 32367440
[TBL] [Abstract][Full Text] [Related]
7. Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis.
Sun L; Huang C; Zhu M; Guo S; Gao Q; Wang Q; Chen B; Li R; Zhao Y; Wang M; Chen Z; Shen B; Zhu W
Theranostics; 2020; 10(26):11950-11962. PubMed ID: 33204322
[No Abstract] [Full Text] [Related]
8. Anoctamin 5 regulates the cell cycle and affects prognosis in gastric cancer.
Fukami T; Shiozaki A; Kosuga T; Kudou M; Shimizu H; Ohashi T; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Morinaga Y; Konishi E; Otsuji E
World J Gastroenterol; 2022 Aug; 28(32):4649-4667. PubMed ID: 36157935
[TBL] [Abstract][Full Text] [Related]
9. Patterns of PD-1, PD-L1, and PD-L2 expression in pediatric solid tumors.
Pinto N; Park JR; Murphy E; Yearley J; McClanahan T; Annamalai L; Hawkins DS; Rudzinski ER
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28488345
[TBL] [Abstract][Full Text] [Related]
10. A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma.
Zhang Y; Xu J; Hua J; Liu J; Liang C; Meng Q; Wei M; Zhang B; Yu X; Shi S
J Immunother Cancer; 2019 Aug; 7(1):233. PubMed ID: 31464648
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma.
Hoffmann F; Zarbl R; Niebel D; Sirokay J; Fröhlich A; Posch C; Holderried TAW; Brossart P; Saavedra G; Kuster P; Strieth S; Gielen GH; Ring SS; Dietrich J; Pietsch T; Flatz L; Kristiansen G; Landsberg J; Dietrich D
Clin Epigenetics; 2020 Jun; 12(1):94. PubMed ID: 32586358
[TBL] [Abstract][Full Text] [Related]
12. Effects of TRPV2 on the Expression of PD-L1 and Its Binding Ability to PD-1 in Gastric Cancer.
Shiozaki A; Fukami T; Shimizu H; Kosuga T; Kudou M; Takemoto K; Katsurahara K; Nishibeppu K; Ohashi T; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Otsuji E
Ann Surg Oncol; 2023 Dec; 30(13):8704-8716. PubMed ID: 37599296
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis and clinical significance of sodium iodide symporter expression in gastric cancer.
Shiozaki A; Ariyoshi Y; Iitaka D; Kosuga T; Shimizu H; Kudou M; Konishi T; Shoda K; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Marunaka Y; Ichikawa D; Otsuji E
Gastric Cancer; 2019 May; 22(3):473-485. PubMed ID: 30191346
[TBL] [Abstract][Full Text] [Related]
14. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin-induced programmed cell death ligand-2 expression is associated with metastasis ability in oral squamous cell carcinoma.
Sudo S; Kajiya H; Okano S; Sasaki M; Katsumata Y; Ohno J; Ikebe T; Hiraki A; Okabe K
Cancer Sci; 2020 Apr; 111(4):1113-1123. PubMed ID: 32012401
[TBL] [Abstract][Full Text] [Related]
16. CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.
Zhang Y; Yin W; Cao W; Chen P; Bian L; Ni Q
Oncol Rep; 2019 Apr; 41(4):2471-2481. PubMed ID: 30816466
[TBL] [Abstract][Full Text] [Related]
17. Psoriasin overexpression confers drug resistance to cisplatin by activating ERK in gastric cancer.
Li L; Cui Y; Ye L; Zhao Z; Jiang WG; Ji J
Int J Oncol; 2018 Sep; 53(3):1171-1182. PubMed ID: 29956751
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
Li C; Cai S; Wang X; Jiang Z
Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
[TBL] [Abstract][Full Text] [Related]
19. The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
Shin SJ; Jeon YK; Cho YM; Lee JL; Chung DH; Park JY; Go H
Oncologist; 2015 Nov; 20(11):1253-60. PubMed ID: 26424759
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological, immune and molecular correlates of
Lingohr P; Dohmen J; Semaan A; Branchi V; Dietrich J; Bootz F; Kalff JC; Matthaei H; Dietrich D
Epigenomics; 2019 May; 11(6):639-653. PubMed ID: 30821175
[No Abstract] [Full Text] [Related]
[Next] [New Search]
